Cytosorbents CorporationCTSONASDAQ
Loading
Year-over-year book value per share growth
Percentile
P31
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -22.33% |
| Q2 2025 | -22.72% |
| Q1 2025 | 17.96% |
| Q4 2024 | -14.54% |
| Q3 2024 | -22.92% |
| Q2 2024 | -11.65% |
| Q1 2024 | -33.08% |
| Q4 2023 | 24.94% |
| Q3 2023 | -23.79% |
| Q2 2023 | -17.43% |
| Q1 2023 | -18.52% |
| Q4 2022 | -9.42% |
| Q3 2022 | -17.73% |
| Q2 2022 | -15.90% |
| Q1 2022 | -10.05% |
| Q4 2021 | -12.70% |
| Q3 2021 | -5.49% |
| Q2 2021 | -5.63% |
| Q1 2021 | -2.67% |
| Q4 2020 | -1.27% |
| Q3 2020 | 189.35% |
| Q2 2020 | 6.29% |
| Q1 2020 | 495.53% |
| Q4 2019 | -49.38% |
| Q3 2019 | -41.84% |
| Q2 2019 | -23.93% |
| Q1 2019 | -11.99% |
| Q4 2018 | -16.66% |
| Q3 2018 | -9.90% |
| Q2 2018 | 44.56% |
| Q1 2018 | 37.95% |
| Q4 2017 | 6.23% |
| Q3 2017 | 18.61% |
| Q2 2017 | 559.82% |
| Q1 2017 | -230.89% |
| Q4 2016 | -134.35% |
| Q3 2016 | -64.66% |
| Q2 2016 | -37.82% |
| Q1 2016 | -26.71% |
| Q4 2015 | -9.95% |